Atezolizumab, pembrolizumab, nivolumab in urothelial carcinoma: studies of direct comparison are useful

4 January 2018 - Four dossier assessments involving comparisons between immunotherapies and chemotherapies for the same therapeutic indication in 2017/comparison ...

Read more →

German watchdog calls for direct comparison of cancer immunotherapies

16 January 2018 - Germany’s drug assessment body has criticized a lack of data directly comparing drugs in a promising ...

Read more →